Continuous manufacturing offers solution to gene therapy viral vector shortage

gene therapy 2
The New Jersey Innovation Institute signed an agreement in March 2019 with Pall Corporation to develop a BioPharmaceutical Innovation iLab to help fix the viral vector shortage using continuous manufacturing.